MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-05-0011139
Doleshwor Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹5.93 Cr
▼ 36% YoY
Net profit · FY 2025
₹12.17 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹40.4 Lakh
EBITDA margin 6.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹4.6 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Doleshwor Pharmaceuticals Private Limited
Data last updated:
Doleshwor Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2015PTC286607. Its GSTIN is 07AAFCD5018B1Z6 (Delhi).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Dipak Kumar Tibrewal and Rajesh Kumar Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House Pvt – 26/16A Plot No – 26 North Portion, Parking Floor Blk – A Rama Road Indus. Area Najafgarh Road, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.93 Cr, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹12.17 Lakh (net margin 2.1%) and EBITDA of ₹40.4 Lakh (EBITDA margin 6.8%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹4.6 Cr on record.
Doleshwor Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-05-0011139). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website doleshwor.com.
Company details
CIN U74900DL2015PTC286607
Registration Number 286607
Incorporation Date 20 October 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-05-0011139
Recognitions & Rankings of Doleshwor Pharmaceuticals
Contact details
Doleshwor Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is doleshwor.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHouse Pvt – 26/16A Plot No – 26 North Portion, Parking Floor Blk – A Rama Road Indus. Area Najafgarh Road, New Delhi, Delhi, India – 110015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Doleshwor Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Doleshwor Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Doleshwor Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Doleshwor Pharmaceuticals Private Limited, buy the company report.
Financials of Doleshwor Pharmaceuticals Private Limited
FY 2025 filings availableDoleshwor Pharmaceuticals Private Limited reported revenue of ₹5.93 Cr (down 36% YoY) for FY 2025.
Revenue · FY 2025
₹5.93 Cr ▼ 36%
Net profit · FY 2025
₹12.17 Lakh margin 2.1%
EBITDA · FY 2025
₹40.4 Lakh margin 6.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 36%
3 years · compounded
▼ 17%
5 years · compounded
▼ 11%
EBITDA CAGR growth
3 years · compounded
▼ 4%
5 years · compounded
▼ 9%
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 36% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹40.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Doleshwor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Doleshwor Pharmaceuticals Private Limited
Doleshwor Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dipak Kumar Tibrewal Also directs: Supravitz Lifesciences Private Limited | Director | 20 Oct 2015 | 11 Years 0 Months | Current |
| Rajesh Kumar Agarwal | Director | 20 Oct 2015 | 11 Years 0 Months | Current |
Peer comparison
Doleshwor Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Donas Drugs and Pharmaceuticals Private Limited | ₹5.93 Cr (FY 2020) | -11.0% | Chennai, Tamil Nadu, India | |||
| United Forum Pharma Distributors Private Limited | ₹5.93 Cr (FY 2024) | 8.0% | Alipurduar, West Bengal, India | |||
| Doleshwor Pharmaceuticals Private Limitedthis company | ₹5.93 Cr (FY 2025) | ₹12.17 Lakh | 2.1% | -36.0% | New Delhi, Delhi, India | |
| Walton Health Care Private Limited | ₹5.91 Cr (FY 2025) | -20.0% | Salem, Tamil Nadu, India | |||
| Disha Apis Private Limited | ₹5.91 Cr (FY 2024) | -29.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Doleshwor Pharmaceuticals Private Limited, buy the company report.
Auditor
Doleshwor Pharmaceuticals Private Limited is audited by ARUN K. AGARWAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARUN K. AGARWAL & ASSOCIATES | FY 2023 | 003917N |
Shareholding
The shareholding of Doleshwor Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Doleshwor Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.6 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jan 2024 | 100852926 | Axis Bank Limited | ₹2.6 Cr | Open | |
| 29 Dec 2020 | 100401854 | Axis Bank Limited | ₹2 Cr | Open |
To see the full charge records of Doleshwor Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Doleshwor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Doleshwor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Doleshwor Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCD5018B1Z6 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Doleshwor Pharmaceuticals Private Limited, buy the company report.
Recent activity
Doleshwor Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Dipak Kumar Tibrewal was appointed as Director on 20 Oct 2015.
AGM
Doleshwor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Doleshwor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Axis Bank Limited of Rs. 260.00 Lakh registered on 18 Jan 2024 with Charge ID 100852926 was modified on 28 Feb 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 260.00 Lakh with Charge ID 100852926 was registered on 18 Jan 2024.
Charges
A charge with Axis Bank Limited of Rs. 200.00 Lakh registered on 29 Dec 2020 with Charge ID 100401854 was modified on 15 Apr 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 100401854 was registered on 29 Dec 2020.
Appointed
Dipak Kumar Tibrewal was appointed as Director.
Appointed
Rajesh Kumar Agarwal was appointed as Director.
Incorporation
20 Oct 2015
Doleshwor Pharmaceuticals Private Limited was registered on 20 Oct 2015 with Roc Delhi & aged 11 years 26 days as per MCA records.
Frequently asked questions
Doleshwor Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 October 2015 (11+ years old) and is registered under CIN U74900DL2015PTC286607.
Doleshwor Pharmaceuticals has 2 current directors:
- Dipak Kumar Tibrewal - Director
- Rajesh Kumar Agarwal - Director
The latest financial statements of Doleshwor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Doleshwor Pharmaceuticals is 07AAFCD5018B1Z6, registered in Delhi.
The CIN (Corporate Identification Number) of Doleshwor Pharmaceuticals is U74900DL2015PTC286607. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Doleshwor Pharmaceuticals was incorporated on 20 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Doleshwor Pharmaceuticals by revenue are Donas Drugs and Pharmaceuticals Private Limited, United Forum Pharma Distributors Private Limited, Walton Health Care Private Limited, Disha Apis Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Dipak Kumar Tibrewal was appointed as Director on 20 Oct 2015. Rajesh Kumar Agarwal was appointed as Director on 20 Oct 2015.
Yes, Doleshwor Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-05-0011139).
Doleshwor Pharmaceuticals can be reached through the website doleshwor.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Doleshwor Pharmaceuticals is at House Pvt – 2616A Plot No – 26 North Portion, Parking Floor Blk – A Rama Road Indus. Area Najafgarh Road, New Delhi, Delhi, India – 110015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages